Judith Penkert

Cancer Risks Associated With Germline<i>PALB2</i>Pathogenic Variants: An International Study of 524 Families

Xin Yang, Goska Leslie, Alicja Doroszuk et al. · Journal of Clinical Oncology · 2019 · 418 citations · Full text

Life Sciences, Genetics, Oncology +17

The identification of pathogenic variants in <i>BRCA1/2</i> negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of <i>FANCM</i> pathogenic variants

Stephanie Schubert, Jana Lisa van Luttikhuizen, Bernd Auber et al. · International Journal of Cancer · 2018 · 87 citations · Full text

Life Sciences, Genetics, Oncology +17

Clustering of TP53 variants into functional classes correlates with cancer risk and identifies different phenotypes of Li-Fraumeni syndrome

Emilie Montellier, Judith Penkert, Claire Freyçon et al. · iScience · 2024 · 23 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity

Judith Penkert, Gunnar Schmidt, Winfried Hofmann et al. · Breast Cancer Research · 2018 · 19 citations · Full text

Life Sciences, Genetics, Oncology +17

Plasma Metabolome Signature Indicative of BRCA1 Germline Status Independent of Cancer Incidence

Judith Penkert, André Märtens, Martin Seifert et al. · Frontiers in Oncology · 2021 · 13 citations · Full text

Medicine, Genetics, Oncology +17